FDA NDC Directory · JSON-LD · Markdown

Rybrevant

NDC 57894-501 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameamivantamab-vmjw
Labeler / ManufacturerJanssen Biotech, Inc.
Marketing categoryBiologic License Application · App BLA761210
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsAMIVANTAMAB (350 mg/1)
Marketing started20210521
Package count1

External sources

Source: openFDA. Public-domain (CC0).